Literature DB >> 8174836

Lipid and apolipoprotein B48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulin-deficient rats.

I J Martins1, A J Sainsbury, J C Mamo, T G Redgrave.   

Abstract

In insulin-deficient streptozotocin-treated rats the intestine is hypertrophic and cholesterol synthesis and transport from the intestine are increased. The increased load of cholesterol is transported through the mesenteric lymph in chylomicrons. Clearance from plasma of injected chylomicrons is slowed in insulin-deficient rats, but the underlying mechanisms are currently unresolved. Hyperphagia may increase the size of chylomicrons which could contribute to defective chylomicron clearance in insulin-deficiency. In the present experiments we compared the size and number of chylomicrons in mesenteric lymph of control rats and diabetic rats infused with fat at two levels. In control and diabetic lymph-cannulated rats, as the infused dose of lipid increased the transport of triglyceride increased substantially compared with fasted rats. In contrast the transport of apoB48 increased by only a small amount during fat transport. Therefore, increased lipid transport was accomplished mostly by increased particle size, with only small increases in numbers of particles in intestinal lymph. Insulin-deficiency had no effect on triglyceride or apoB48 transport in lymph. Calculations suggested that each chylomicron particle contained a single molecule of apoB48. When hyperphagia in diabetic rats was prevented, the plasma triglycerides were decreased but the slow plasma clearance of injected chylomicron-like emulsions persisted. Hyperphagia, therefore, was unconnected to the impairment in chylomicron metabolism in insulin-deficient rats. Changes in the association with plasma apolipoproteins, in the expression of receptors for uptake of chylomicron remnants or in exposure to endothelial lipases may be responsible for the defective clearance of triacylglycerol-rich lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174836     DOI: 10.1007/bf00398049

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  40 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Separation of plasma lipoproteins by density-gradient ultracentrifugation.

Authors:  T G Redgrave; D C Roberts; C E West
Journal:  Anal Biochem       Date:  1975-05-12       Impact factor: 3.365

3.  Fractionation of the C-apoproteins from human plasma very low density lipoproteins.

Authors:  P N Herbert; R S Shulman; R I Levy; D S Fredrickson
Journal:  J Biol Chem       Date:  1973-07-25       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon.

Authors:  S H Chen; G Habib; C Y Yang; Z W Gu; B R Lee; S A Weng; S R Silberman; S J Cai; J P Deslypere; M Rosseneu
Journal:  Science       Date:  1987-10-16       Impact factor: 47.728

6.  Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man.

Authors:  T G Redgrave; H L Ly; E C Quintao; C F Ramberg; R C Boston
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

7.  Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal.

Authors:  J S Cohn; J R McNamara; S D Cohn; J M Ordovas; E J Schaefer
Journal:  J Lipid Res       Date:  1988-07       Impact factor: 5.922

8.  Mesenteric lymph apolipoproteins in control and ethinyl estradiol-treated rats: a model for studying apolipoproteins of intestinal origin.

Authors:  B R Krause; C H Sloop; C K Castle; P S Roheim
Journal:  J Lipid Res       Date:  1981-05       Impact factor: 5.922

9.  Cholesterol-lowering effect of N-(alpha-methylbenzyl)linoleamide (melinamide) in cholesterol-fed diabetic rats.

Authors:  K Matsubara; Y Matsuzawa; S Jiao; S Kihara; T Takama; T Nakamura; K Tokunaga; M Kubo; S Tarui
Journal:  Atherosclerosis       Date:  1988-08       Impact factor: 5.162

10.  Apolipoprotein B synthesis in rat small intestine: regulation by dietary triglyceride and biliary lipid.

Authors:  N O Davidson; M E Kollmer; R M Glickman
Journal:  J Lipid Res       Date:  1986-01       Impact factor: 5.922

View more
  8 in total

1.  Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48.

Authors:  A Curtin; P Deegan; D Owens; P Collins; A Johnson; G H Tomkin
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

Review 2.  Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Yoshiharu Tokita; Takeaki Nagamine; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Kimber L Stanhope; Peter J Havel; Mitsuyo Okazaki; Masumi Ai; Akira Tanaka
Journal:  Clin Chim Acta       Date:  2011-04-19       Impact factor: 3.786

3.  Intestinally derived lipoprotein particles in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia.

Authors:  A Curtin; P Deegan; D Owens; P Collins; A Johnson; G H Tomkin
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

4.  Alterations in apolipoprotein B-48 in the postprandial state in NIDDM.

Authors:  A Curtin; P Deegan; D Owens; P Collins; A Johnson; G H Tomkin
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

5.  The expression of genes involved in jejunal lipogenesis and lipoprotein synthesis is altered in morbidly obese subjects with insulin resistance.

Authors:  Carolina Gutierrez-Repiso; Francisca Rodriguez-Pacheco; Juan Garcia-Arnes; Sergio Valdes; Montserrat Gonzalo; Federico Soriguer; Francisco J Moreno-Ruiz; Alberto Rodriguez-Cañete; Jose L Gallego-Perales; Guillermo Alcain-Martinez; Luis Vazquez-Pedreño; Soledad Lopez-Enriquez; Sara Garcia-Serrano; Lourdes Garrido-Sanchez; Eduardo Garcia-Fuentes
Journal:  Lab Invest       Date:  2015-09-14       Impact factor: 5.662

Review 6.  Overnutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in Neurodegenerative Diseases.

Authors:  Ian James Martins
Journal:  Int J Mol Sci       Date:  2015-12-10       Impact factor: 5.923

7.  Consumption of low doses of fat prevents the postprandial rise in chylomicron particle concentration and remnant accumulation in healthy normolipidaemic males.

Authors:  Anthony P James; John C Mamo
Journal:  J Nutr Sci       Date:  2012-08-01

8.  Human intestinal lipid storage through sequential meals reveals faster dinner appearance is associated with hyperlipidemia.

Authors:  Miriam Jacome-Sosa; Qiong Hu; Camila M Manrique-Acevedo; Robert D Phair; Elizabeth J Parks
Journal:  JCI Insight       Date:  2021-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.